As we grow older and enter middle age, thoughts about our health and its implications for the future become more pronounced: particularly when it comes to cancer. The mere mention of “the big ‘C’” is enough to prompt us to change the subject, or even experience feelings of panic. This is even more stressful when […]
MiraKind
How to Find a Menopause Doctor
Menopause happens to all women at some point in their lives. Even though it is a normal and natural process, there is still a gap in knowledge surrounding menopause — nearly half of women surveyed globally in 20231 did not feel informed about menopause. Additionally, healthcare professionals, including OB/GYNs, do not have any mandatory training […]
Menopause and mental health
May is mental health awareness month, so this month we want to talk about menopause and mental health. Did you know that depression in women doubles around menopause?1,2 While most people know about hot flashes and menopause, many do not know that those same hormonal shifts often cause mental health changes.1,3 The hormonal changes that […]
What are the First Signs of Menopause?
The first signs of menopause are the symptoms women experience during a period called perimenopause, which can start up to 10 years before menopause. Since menopause is defined by not having a period for a year, most of the symptoms we associate with menopause (aka hot flashes) actually begin during perimenopause. At MiraKind, we believe perimenopause […]
Breast cancer risk factors
Last month, we looked at two different types of genetic variants: BRCA variants and the KRAS-variant. Both BRCA and KRAS are pathogenic variants that are linked to an increased risk of breast cancer. In this month’s blog post, we’re going to dive into the general accepted breast cancer risk factors. To give you a high […]
Understanding different genetic causes of cancer: BRCA variants vs. the KRAS-variant
This post explores BRCA variants vs. the KRAS-variant and is part two in our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic variants and mutations, specifically the KRAS-variant and KRAS mutations. Quick recap on genetics and cancer development In our last blog post, we learned […]
Understanding the different causes of cancer: genetic variants vs. genetic mutations
Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. For Part 1, we’ll discuss the KRAS-variant and KRAS mutations. Genes and cancer development: Gene Variants vs Mutations Cancer is caused by genetic differences in the DNA you are born with, by […]
Gennev Podcast Recap: HRT, Breast Cancer, Estrogen, and Menopause
Want to learn more about menopause, hormone replacement therapy (HRT), estrogen, and breast cancer risk? Why not sit down, pop in some headphones, and listen to this podcast from our partners at Gennev. Jill Angelo, CEO and founder of Gennev, discusses these topics with Dr. Arvum Bluming, Dr. Rebecca Dunsmoor-Su, and Mirakind’s own Dr. Joanne […]
New Clinical Trial for Treatment in Prostate Cancer Patients with Specific Genetic Biomarkers
Over the years, Mirakind has shared research and information about the KRAS-variant and how it can have many health implications – from cancer to autoimmunity to response to hormone replacement therapy. Now, we’re excited to share with you some new findings concerning other genetic mutations, like the KRAS-variant, that could help guide treatment decisions for […]
Clinical Trial for Patients with the KRAS-variant and HNSCC
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want to share with you continuing research investigating how the KRAS-variant is important in predicting how a cancer patient responds to cancer treatment, including […]
MiraKind Responds to the COVID-19 Pandemic
At MiraKind, we believe knowledge is power. That belief has never held truer than today, as we face a global pandemic that can only be stamped out with knowledge–knowledge of who is infected so that we can prevent further spread of COVID-19. In response to the COVID-19 pandemic, MiraKind is using charitable donations to provide […]
Dr. Joanne Weidhaas to speak at TEDxCulverCity
Our founder, Dr. Joanne Weidhaas will be giving her first “TED talk” as an invited speaker at TEDxCulverCity on March 31, 2020! Joanne is a radiation oncologist and cancer researcher, and she is the Director of the Division of Cellular and Molecular Oncology at UCLA. She’s also the founder of two companies, MiraDx and MiraKind, […]
